These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22588543

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D, Coffin RS, Anderson PN.
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD, Schwab ME.
    Ann Med; 2005 Feb; 37(8):556-67. PubMed ID: 16338758
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
    Giger RJ, Venkatesh K, Chivatakarn O, Raiker SJ, Robak L, Hofer T, Lee H, Rader C.
    Restor Neurol Neurosci; 2008 Feb; 26(2-3):97-115. PubMed ID: 18820405
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G, Tang WY.
    Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury.
    Deng Q, Cai W, Li S, Zhang Y, Su B.
    Brain Res Bull; 2013 Oct; 99():140-4. PubMed ID: 24184005
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X, Zahir T, Mothe A, Shoichet MS, Morshead CM, Katayama Y, Tator CH.
    Cell Transplant; 2012 Oct; 21(6):1177-97. PubMed ID: 22236767
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
    Gonzenbach RR, Zoerner B, Schnell L, Weinmann O, Mir AK, Schwab ME.
    J Neurotrauma; 2012 Feb 10; 29(3):567-78. PubMed ID: 21815784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE, Liu BP, Park JH, Strittmatter SM.
    Neuron; 2004 Oct 28; 44(3):439-51. PubMed ID: 15504325
    [Abstract] [Full Text] [Related]

  • 17. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M.
    Proc Natl Acad Sci U S A; 2005 Jan 25; 102(4):1205-10. PubMed ID: 15647357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regulation of Nogo and Nogo receptor during the development of the entorhino-hippocampal pathway and after adult hippocampal lesions.
    Mingorance A, Fontana X, Solé M, Burgaya F, Ureña JM, Teng FY, Tang BL, Hunt D, Anderson PN, Bethea JR, Schwab ME, Soriano E, del Río JA.
    Mol Cell Neurosci; 2004 May 25; 26(1):34-49. PubMed ID: 15121177
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.